Loading...
Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
Recent discoveries suggest that the critical events leading to the anti-proliferative activity of the IMiD immunomodulatory agents lenalidomide and pomalidomide in multiple myeloma (MM) cells are initiated by Cereblon-dependent ubiquitination and proteasomal degradation of substrate proteins Ikaros...
Na minha lista:
Udgivet i: | Blood Cancer J |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635186/ https://ncbi.nlm.nih.gov/pubmed/26430725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.66 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|